About Eppix Labs · Canadian research peptide supplier
Every Batch Tested. Every Certificate Public. Nothing Sold Below 99%.
Eppix Labs supplies research peptides across Canada from Canadian stock. We were built on one rule: if a purity number is on the label, the independent lab report behind it is published against that lot, where anyone can check it.
- 56
- research peptides in stock
- 45
- certificates published
- 99%+
- HPLC purity floor, every lot
- 1–2 days
- Xpresspost across Canada
What Eppix Labs Does
We stock research peptides in Canada for laboratories and researchers and ship them by Canada Post Xpresspost, same day before 4 pm. Every compound in the catalog is supplied for in vitro and laboratory research purposes only — we provide no dosing, administration or protocol guidance, and nothing on this site describes what a compound does in humans.
What makes us different is not the catalog; several Canadian suppliers stock similar compounds. It is that every lot we sell has an independent Janoshik Analytical report — HPLC purity and mass-spec identity — published in full on our certificate library, matched to the lot number printed on the vial, and linked to the same result on the lab’s own portal.
Why It Matters
A purity percentage tells you what fraction of the material in a vial is the compound on the label. It says nothing about how much material is there. A vial can be highly pure and still short-filled. That is why we publish two numbers for every lot: HPLC purity and measured content in milligrams against the label claim.
We don’t publish purity figures we haven’t tested for, and we never reuse a certificate from a previous batch on new stock. If a lot number isn’t in our library, it didn’t come from us.
The Eppix Verification Standard
Step 01 · Before release
Independent lab analysis
Each lot is sent to Janoshik Analytical after fill. The lab runs HPLC for purity and mass spectrometry for identity, and reports the milligrams actually found in the vial.
Step 02 · The floor
99% or it is not sold
A lot that tests below 99% HPLC purity is not released for sale in Canada. Only lots meeting the floor appear in the certificate library and on the store.
Step 03 · Published
Certificate matched to the vial
The full report is published on our certificate library under the lot number printed on the label, with a link to the same report on verify.janoshik.com. No PDF-only, no summaries.
Live From the Certificate Library
Every research peptide batch Eppix has published, ranked by the purity on its certificate and updated the moment a new lot is added. These are the same numbers a researcher sees on the certificate; nothing here is typed in by hand.
This analysis covers the 45 lots at or above the 99% research floor. 7 further lots on file tested below it and are not listed for sale. The lots meeting the floor are in the certificate library.
Lots in this feed
45
of 52 on file
Compounds
31
plus 11 blend lots
Mean purity
99.649%
single-compound lots
Median purity
99.753%
Lowest / highest
99.02% / 99.92%
KPV Peptide / Livagen
Measured content vs label
114.2%
average over 45 lots with a figure
Latest test date
Sep 8, 2026
Laboratory of record
Janoshik
named on every certificate
Purity by Compound, Ranked
HPLC purity of the latest published lot per compound. The axis starts at the 99% floor, not at zero, because every lot in the feed sits between 99% and 100%.
- Livagen99.917%
- Tirzepatide99.888%
- Melanotan 299.887%
- PT-14199.864%
- Vesugen99.857%
- GHK-Cu99.848%
- Kisspeptin-1099.824%
- Eloralintide99.810%
- Melanotan-199.794%
- Cartalax99.784%
- CJC-1295 No DAC99.777%
- SS-3199.768%
- BPC-15799.765%
- PE-22-2899.754%
- Ipamorelin99.753%
- Retatrutide99.734%
- NA-Selank99.712%
- Thymosin Alpha-199.699%
- ARA-29099.683%
- DSIP99.623%
- Cagrilintide99.605%
- 5-Amino-1MQ99.550%
- Semaglutide99.504%
- Tesamorelin99.375%
- NA-Semax99.303%
- MOTS-c99.252%
- TB-50099.182%
- Selank99.161%
- KPV Peptide99.023%
- Semax≥99%
- NAD+≥99%
Compare Two Compounds
Retatrutide
✓ ≥ 99%- Latest lot purity
- 99.734% (-0.154 vs Tirzepatide)
- Rank (latest lot)
- #16 of 31
- Lots on file
- 5 · avg 99.694% · best 99.820% · lowest 99.577%
- Measured content
- 100.6–123.4% of label across 5 lots
- Sizes tested
- 50mg, 40mg, 10mg, 20mg, 100mg
- Latest batch
- RETA-CA-26H-100 · 100mg · 2026-09-08 · Janoshik
- Category
- Metabolic & GLP-1
- Product
- buy retatrutide in Canada
Lot history
Tirzepatide
✓ ≥ 99%- Latest lot purity
- 99.888% (+0.154 vs Retatrutide)
- Rank (latest lot)
- #2 of 31
- Lots on file
- 4 · avg 99.802% · best 99.888% · lowest 99.634%
- Measured content
- 110.6–118.3% of label across 4 lots
- Sizes tested
- 30mg, 60mg, 10mg, 15mg
- Latest batch
- TIRZ-CA-26G-15 · 15mg · 2026-08-25 · Janoshik
- Category
- Metabolic & GLP-1
- Product
- buy tirzepatide in Canada
Lot history
Lot History — Every Published Lot at or Above the Floor
45 lots across 31 compounds. Verify opens the laboratory’s own record for that lot.
| # | Compound | Category | Strength | Batch | Tested | Lab | Purity | Measured vs label | Verify |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Livagen | Research peptide | 20mg | LIVE-CA-26F-20 | Jul 21, 2026 | Janoshik | 99.917% | 24.39 mg (122%) | verify |
| 2 | Tirzepatide | Metabolic & GLP-1 | 15mg | TIRZ-CA-26G-15 | Aug 25, 2026 | Janoshik | 99.888% | 17.74 mg (118.3%) | verify |
| 3 | Melanotan 2 | Hormonal Signaling | 10mg | MT2-CA-26F-10 | Jul 13, 2026 | Janoshik | 99.887% | 11.12 mg (111.2%) | verify |
| 4 | Tirzepatide | Metabolic & GLP-1 | 60mg | TIRZ-CA-26F-60 | Aug 4, 2026 | Janoshik | 99.867% | 67.71 mg (112.8%) | verify |
| 5 | PT-141 | Hormonal Signaling | 10mg | PT-CA-26A-01 | Jan 30, 2026 | Janoshik | 99.864% | 11.86 mg (118.6%) | verify |
| 6 | Vesugen | Research peptide | 20mg | VESU-CA-26G-20 | Jul 27, 2026 | Janoshik | 99.857% | 21.04 mg (105.2%) | verify |
| 7 | GHK-Cu | Tissue Repair | 100mg | GHKC-CA-26F-100 | Jul 3, 2026 | Janoshik | 99.848% | 111.26 mg (111.3%) | verify |
| 8 | GHK-Cu | Tissue Repair | 50mg | GHK-CA-26A-02 | Mar 23, 2026 | Janoshik | 99.835% | 61.87 mg (123.7%) | verify |
| 9 | Kisspeptin-10 | Hormonal Signaling | 10mg | KSPN-CA-26G-10 | Jul 13, 2026 | Janoshik | 99.824% | 13.21 mg (132.1%) | verify |
| 10 | Tirzepatide | Metabolic & GLP-1 | 30mg | TIRZ-CA-26A-01 | Jun 3, 2026 | Janoshik | 99.820% | 33.17 mg (110.6%) | verify |
| 11 | Retatrutide | Metabolic & GLP-1 | 50mg | RETA-CA-26C-01 | Apr 10, 2026 | Janoshik | 99.820% | 54.93 mg (109.9%) | verify |
| 12 | Eloralintide | Research peptide | 10mg | ELOR-CA-26G-10 | Jul 24, 2026 | Janoshik | 99.810% | 12.42 mg (124.2%) | verify |
| 13 | KPV Peptide | Tissue Repair | 30mg | KPV-CA-26A-01 | Jan 19, 2026 | Janoshik | 99.801% | 37.52 mg (125.1%) | verify |
| 14 | Melanotan-1 | Research peptide | 10mg | MT1-CA-26F-10 | Jul 24, 2026 | Janoshik | 99.794% | 10.6 mg (106%) | verify |
| 15 | SS-31 | Longevity | 100mg | SS31-CA-26F-100 | Jul 8, 2026 | Janoshik | 99.788% | 94.35 mg (94.3%) | verify |
| 16 | Cartalax | Longevity | 20mg | CART-CA-26F-20 | Jul 3, 2026 | Janoshik | 99.784% | 20.64 mg (103.2%) | verify |
| 17 | CJC-1295 No DAC | Growth Hormone | 10mg | CJND-CA-26F-10 | Jul 3, 2026 | Janoshik | 99.777% | 10.76 mg (107.6%) | verify |
| 18 | SS-31 | Longevity | 50mg | SS31-CA-26F-50 | Jul 26, 2026 | Janoshik | 99.768% | 50.86 mg (101.7%) | verify |
| 19 | BPC-157 | Tissue Repair | 10mg | BPC-CA-26F-10 | Jun 26, 2026 | Janoshik | 99.765% | 10.98 mg (109.8%) | verify |
| 20 | PE-22-28 | Research peptide | 10mg | PE22-CA-26F-01 | Jun 29, 2026 | Janoshik | 99.754% | 12.86 mg (128.6%) | verify |
| 21 | Ipamorelin | Growth Hormone | 10mg | IPAM-CA-26G-10 | Aug 24, 2026 | Janoshik | 99.753% | 11.75 mg (117.5%) | verify |
| 22 | Retatrutide | Metabolic & GLP-1 | 100mg | RETA-CA-26H-100 | Sep 8, 2026 | Janoshik | 99.734% | 114.02 mg (114%) | verify |
| 23 | NA-Selank | Research peptide | 10mg | NSLK-CA-26G-10 | Aug 17, 2026 | Janoshik | 99.712% | 11.88 mg (118.8%) | verify |
| 24 | Retatrutide | Metabolic & GLP-1 | 40mg | RETA-CA-26F-40 | Jul 13, 2026 | Janoshik | 99.703% | 40.23 mg (100.6%) | verify |
| 25 | Thymosin Alpha-1 | Longevity | 10mg | TA1-CA-26F-10 | Jul 21, 2026 | Janoshik | 99.699% | 11.64 mg (116.4%) | verify |
| 26 | ARA-290 | Research peptide | 16mg | ARA2-CA-26G-16 | Aug 20, 2026 | Janoshik | 99.683% | 19.28 mg (120.5%) | verify |
| 27 | Retatrutide | Metabolic & GLP-1 | 10mg | RETA-CA-26F-10 | Jul 13, 2026 | Janoshik | 99.637% | 11.76 mg (117.6%) | verify |
| 28 | Tirzepatide | Metabolic & GLP-1 | 10mg | TIRZ-CA-26G-10 | Aug 4, 2026 | Janoshik | 99.634% | 11.42 mg (114.2%) | verify |
| 29 | DSIP | Cognitive | 10mg | DSIP-CA-26F-10 | Jun 26, 2026 | Janoshik | 99.623% | 11.85 mg (118.5%) | verify |
| 30 | Cagrilintide | Metabolic & GLP-1 | 10mg | CAGL-CA-26G-10 | Aug 19, 2026 | Janoshik | 99.605% | 11.66 mg (116.6%) | verify |
| 31 | Retatrutide | Metabolic & GLP-1 | 20mg | RETA-CA-26F-20 | Jul 21, 2026 | Janoshik | 99.577% | 24.68 mg (123.4%) | verify |
| 32 | 5-Amino-1MQ | Metabolic & GLP-1 | 10mg | 51Q-CA-26A-01 | Feb 6, 2026 | Janoshik | 99.550% | 11.17 mg (111.7%) | verify |
| 33 | Semaglutide | Metabolic & GLP-1 | 10mg | SEMA-CA-26F-10 | Jun 26, 2026 | Janoshik | 99.504% | 11.27 mg (112.7%) | verify |
| 34 | Cagrilintide | Metabolic & GLP-1 | 5mg | CAG-CA-26A-01 | Jan 12, 2026 | Janoshik | 99.446% | 5.62 mg (112.4%) | verify |
| 35 | Tesamorelin | Growth Hormone | 20mg | TESA-CA-26F-20 | Jul 3, 2026 | Janoshik | 99.375% | 22.6 mg (113%) | verify |
| 36 | MOTS-c | Longevity | 10mg | MOTS-CA-26A-02 | Jan 23, 2026 | Janoshik | 99.340% | 12.65 mg (126.5%) | verify |
| 37 | NA-Semax | Research peptide | 10mg | NASA-CA-26F-10 | Jul 13, 2026 | Janoshik | 99.303% | 11.58 mg (115.8%) | verify |
| 38 | MOTS-c | Longevity | 20mg | MOTS-CA-26F-20 | Jul 3, 2026 | Janoshik | 99.281% | 22.94 mg (114.7%) | verify |
| 39 | MOTS-c | Longevity | 40mg | MOTS-CA-26G-40 | Jul 9, 2026 | Janoshik | 99.252% | 46.13 mg (115.3%) | verify |
| 40 | TB-500 | Tissue Repair | 10mg | TB5-CA-26F-10 | Jun 29, 2026 | Janoshik | 99.182% | 11.52 mg (115.2%) | verify |
| 41 | Selank | Cognitive | 10mg | SLNK-CA-26F-10 | Jun 26, 2026 | Janoshik | 99.161% | 10.55 mg (105.5%) | verify |
| 42 | KPV Peptide | Tissue Repair | 10mg | KPV-CA-26F-10 | Jul 3, 2026 | Janoshik | 99.023% | 12.05 mg (120.5%) | verify |
| 43 | Semax | Cognitive | 10mg | SMAX-CA-26G-10 | Jul 17, 2026 | Janoshik | ≥99% | 10.69 mg (106.9%) | verify |
| 44 | NAD+ | Longevity | 1000mg | NAD-CA-26F-1000 | Jun 26, 2026 | Janoshik | ≥99% | 1110.51 mg (111.1%) | verify |
| 45 | NAD+ | Longevity | 500mg | NAD-CA-26F-500 | Jun 23, 2026 | Janoshik | ≥99% | 512.17 mg (102.4%) | verify |
Research Blends — Every Published Blend Lot
Blends are tested as a blend, and the report gives a measured mass per component rather than one figure for the vial. That is why they are listed separately: a single purity number would describe a blend wrongly.
| Blend | Measured per component | Strength | Batch | Tested | Lab | Report |
|---|---|---|---|---|---|---|
| CJC-1295 Ipamorelin Blend Canada | 11.47 mg / 10.92 mg | 20mg | CJIP-CA-26G-20 | Aug 17, 2026 | Janoshik | laboratory report |
| Triad-GH Blend Canada | Tesa Ipa CJC-1295 | Tesamorelin 6.74 mg / Ipamorelin 3.61 mg / CJC-1295 (mod GRF 1-29) 3.76 mg | 12mg | TICA-CA-26G-12 | Jul 17, 2026 | Janoshik | laboratory report |
| Tesamorelin Ipamorelin Blend Canada | 10.87 mg / 3.53 mg | 13mg | TIPA-CA-26G-13 | Jul 9, 2026 | Janoshik | laboratory report |
| GLOW Blend Canada | GHK-Cu BPC-157 TB-500 | 63.75 mg / 11.64 mg / 12.16 mg | 70mg | GLOW-CA-26F-70 | Jul 8, 2026 | Janoshik | laboratory report |
| Mito-Genesis Blend Canada | NAD+ 5A1MQ MOTS-c | 99.22 mg / 11.43 mg / 11.14 mg | 120mg | MITO-CA-26F-120 | Jul 3, 2026 | Janoshik | laboratory report |
| Deadpool Blend Canada | Cartalax BPC TB-500 | 10.72 mg / 5.98 mg / 5.75 mg | 20mg | CTBT-CA-26F-20 | Jun 29, 2026 | Janoshik | laboratory report |
| KLOW Blend Canada | GHK-Cu BPC TB-500 KPV | 63.68 mg / 11.30 mg / 12.11 mg / 10.92 mg | 80mg | KLOW-CA-26G-01 | Jun 29, 2026 | Janoshik | laboratory report |
| CJC-1295 Ipamorelin Blend Canada | 5.57 mg / 5.88 mg | 10mg | CJIP-CA-26F-10 | Jun 26, 2026 | Janoshik | laboratory report |
| BPC-157 TB-500 Blend Canada | Wolverine Stack | 6.25 mg / 5.86 mg | 10mg | BPCT-CA-26F-01 | Jun 16, 2026 | Janoshik | laboratory report |
| BPC-157 TB-500 Blend Canada | Wolverine Stack | 12.83 mg / 12.05 mg | 20mg | TBBP-CA-26E-01 | May 8, 2026 | Janoshik | laboratory report |
| Coremend Blend Canada | TB-500 BPC-157 KPV | 11.34 mg / 12.60 mg / 27.97 mg | 45mg | CORE-CA-26D-01 | Apr 27, 2026 | Janoshik | laboratory report |
Testing Cadence
Lots tested per month, from the test dates on the certificates.
- January 20264 lots
- February 20261 lot
- March 20261 lot
- April 20261 lot
- June 20269 lots
- July 202621 lots
- August 20267 lots
- September 20261 lot
What We Stand For
- 01
Independent, not in-house. Every result comes from Janoshik Analytical, a third-party laboratory. We do not self-certify.
- 02
Batch-specific, always. Every product carries a lot number before distribution, and that lot maps to exactly one certificate.
- 03
Publicly linked, not PDF-only. Any researcher can verify a batch directly with the issuing laboratory without contacting us.
- 04
Research use only, without exception. No dosing, no administration, no claims about effects in humans — on the site, in support, or in ads.
- 05
Canadian stock, Canadian delivery. Orders ship within Canada by Canada Post Xpresspost with tracking, free over $200.
Who Is Behind It
Adam Reeves — Research Editor
Compiles compound overviews and COA methodology for the Research Library from peer-reviewed literature and Janoshik reports. Bio and credentials on the author page.
Profile →Contact & Support
Email
Orders, certificates, lot questions
Support hours
8 am – 4 pm MST, daily
Same-day dispatch cut-off 4 pm
Verify a batch
Enter the lot number on the vial
Questions About Eppix Labs
Yes. Eppix Labs stocks and ships research peptides within Canada. Orders are dispatched by Canada Post Xpresspost, and support runs 8 am–4 pm MST at hello@eppixlabs.ca.
Janoshik Analytical, an independent third-party laboratory. Every lot’s HPLC purity and mass-spec identity report is published on our certificate library and can be checked on the lab’s own portal.
We supply research materials to laboratories and researchers. All products are for in vitro and laboratory research purposes only and are not approved by Health Canada for any use in humans or animals.
It is not released for sale. Only lots meeting the 99% HPLC purity floor appear in the certificate library and on the store.
Enter the lot number printed on the label on our Verify page. If it is not in our library, it did not come from Eppix Labs — email us the number and we’ll confirm.
See the certificates before you order
Every lot, every number, verifiable at the lab.
All products are supplied for in vitro and laboratory research purposes only.